title: A novel approach for imaging brain-behavior relationships in mice reveals unexpected metabolic patterns during seizures in the absence of tissue plasminogen activator.
abstract: Medically refractory seizures cause inflammation and neurodegeneration. Seizure initiation thresholds have been linked in mice to the serine protease tissue plasminogen activator (tPA); mice lacking tPA exhibit resistance to seizure induction, and the ensuing inflammation and neurodegeneration are similarly suppressed. Seizure foci in humans can be examined using PET employing 2-deoxy-2[(18)F]fluoro-d-glucose ((18)FDG) as a tracer to visualize metabolic dysfunction. However, there currently exist no such methods in mice to correlate measures of brain activation with behavior. Using a novel method for small animal PET data analysis, we examine patterns of (18)FDG uptake in wild-type and tPA(-/-) mice and find that they correlate with the severity of drug-induced seizure initiation. Furthermore, we report unexpected activations that may underlie the tPA modulation of seizure susceptibility. The methods described here should be applicable to other mouse models of human neurological disease.
authors: Graduate Program in Molecular and Cellular Pharmacology, State University of New York at Stony Brook, Stony Brook, NY 11794, USA.
authors: Martine M
authors: MM
authors: Mirrione
authors: Wynne K
authors: WK
authors: Schiffer
authors: Joanna S
authors: JS
authors: Fowler
authors: Dave L
authors: DL
authors: Alexoff
authors: Stephen L
authors: SL
authors: Dewey
authors: Stella E
authors: SE
authors: Tsirka
mesh_terms: D000818:Animals; D001522:Behavior, Animal; D001921:Brain / Q000000981:diagnostic imaging* / Q000378:metabolism*; D019788:Fluorodeoxyglucose F18 / Q000493:pharmacokinetics*; D008657:Metabolic Clearance Rate; D051379:Mice; D018345:Mice, Knockout; D049268:Positron-Emission Tomography / Q000379:methods; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D012640:Seizures / Q000000981:diagnostic imaging* / Q000378:metabolism*; D010959:Tissue Plasminogen Activator / Q000235:genetics / Q000378:metabolism*
chemical_list: D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18; D010959:Tissue Plasminogen Activator
references: Arq Neuropsiquiatr. 2002 Jun;60(2-A):198-203
references: 12068345
references: Epilepsy Res. 2002 Apr;49(2):109-20
references: 12049799
references: Eur J Neurosci. 2002 Aug;16(4):713-21
references: 12270047
references: Epilepsia. 2003 Apr;44(4):559-64
references: 12681005
references: J Nucl Med. 2003 May;44(5):815-22
references: 12732684
references: Epilepsia. 2003 May;44(5):677-87
references: 12752467
references: J Neurosci. 1996 Mar 15;16(6):2057-63
references: 8604050
references: J Nucl Med. 1996 Feb;37(2):394-9
references: 8667082
references: Eur J Pharmacol. 1997 Jan 14;319(1):21-9
references: 9030893
references: Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4103-8
references: 9108112
references: Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13311-6
references: 9371842
references: Neuron. 1998 Oct;21(4):813-25
references: 9808467
references: Neuroimage. 1999 Jan;9(1):63-80
references: 9918728
references: EMBO J. 1999 Jun 1;18(11):3007-12
references: 10357813
references: Proc Natl Acad Sci U S A. 2005 Jan 11;102(2):443-8
references: 15630096
references: Neuroimage. 2003 Jul;19(3):601-12
references: 12880791
references: IEEE Trans Med Imaging. 2003 Sep;22(9):1042-52
references: 12956260
references: J Neurosci Methods. 2003 Oct 30;129(2):105-13
references: 14511814
references: Proc Natl Acad Sci U S A. 2004 Aug 3;101(31):11438-43
references: 15277673
references: Brain. 2004 Oct;127(Pt 10):2276-85
references: 15282217
references: Brain Res. 1972 Nov 27;47(1):262-8
references: 4641271
references: Brain Res. 1984 Nov 12;321(2):237-53
references: 6498517
references: Neuroscience. 1990;36(2):339-48
references: 2120614
references: Nature. 1993 Feb 4;361(6411):453-7
references: 8429885
references: Neurosci Lett. 1994 Feb 28;168(1-2):225-8
references: 8028781
references: Development. 1994 Nov;120(11):3173-83
references: 7720560
references: Nature. 1995 Sep 28;377(6547):340-4
references: 7566088
references: Science. 1995 Dec 22;270(5244):1992-4
references: 8533091
references: J Neurosci. 2005 Feb 16;25(7):1797-805
references: 15716416
references: J Neural Transm (Vienna). 2005 Mar;112(3):319-30
references: 15723157
references: J Neurosci Methods. 2005 May 15;144(1):25-34
references: 15848236
references: Neuroscience. 2005;135(4):1203-15
references: 16165303
references: Synapse. 2006 Feb;59(2):119-21
references: 16320304
references: Psychopharmacology (Berl). 2006 Jun;186(2):159-67
references: 16703400
references: J Neurosci Methods. 2006 Sep 15;155(2):272-84
references: 16519945
references: Neuroscience. 2006 Oct 27;142(3):871-83
references: 16934946
references: J Neurosci. 2000 Jan 15;20(2):542-9
references: 10632583
references: J Cell Biol. 2000 Mar 20;148(6):1295-304
references: 10725341
references: Nat Biotechnol. 2000 Jun;18(6):655-60
references: 10835605
references: Nat Med. 2001 Jan;7(1):59-64
references: 11135617
references: Arch Neurol. 2001 Jun;58(6):933-9
references: 11405808
references: J Cereb Blood Flow Metab. 2002 Feb;22(2):196-205
references: 11823717
references: J Neurosci. 2002 Mar 15;22(6):2125-34
references: 11896152
references: J Clin Invest. 2002 Jun;109(12):1571-8
references: 12070304